Study Status: RECRUITING
Recruit Status: RECRUITING
Study Type: INTERVENTIONAL
Official Title: Phase II Trial of a Bivalent Vaccine With the Immunological Adjuvant OPT-821 (QS-21), in Combination With Randomization of Oral ?-glucan, for High-Risk Neuroblastoma
Brief Summary: The purpose of this study is to test which treatment schedule of ?-glucan with bivalent vaccine is more effective for participants with high-risk neuroblastoma that is in complete remission.